Pfizer Inc vs SMX Security Matters plc — how do they compare? Pfizer Inc trades at $27.95 (market cap $158.56B), while SMX Security Matters plc trades at $3.79 (market cap $4.13M). The key difference: Pfizer Inc is far larger — about 38392.3× SMX Security Matters plc's market cap, and Pfizer Inc pays a 6.18% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and SMX Security Matters plc for 21 Days on average.
| PFE | SMX | |
|---|---|---|
Market Cap | $158.56B | $4.13M |
Volume | 44,138,282 | 124,362 |
Sector | Health | Industrials |
52-Week High | $29.02 | $74.08K |
52-Week Low | $23.67 | $3.79 |
Typical Hold Time | 158 Days | 21 Days |
Enterprise Value | $210.06B | -$27.20M |
Dividend Yield | 6.18% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
SMX trades at $3.90, up 2.9% today, but faces significant financial challenges with no revenue reported for 2025 and a net loss of $169.18 million. The stock shows bearish technical signals with moving averages indicating selling pressure, though oscillators suggest potential short-term momentum. Recent news highlights the company's focus on recycled plastic verification technology and growing media coverage from major outlets.
The outlook remains highly speculative given the absence of revenue and substantial losses. Investment opportunity hinges on successful commercialization of SMX's material verification platform, while risks include cash burn sustainability and intense competition in the circular economy space. Wall Street sentiment appears cautious due to the company's unproven business model.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →